Gemcitabine as single agent in the treatment of relapsed or refractory aggressive non-Hodgkin lymphoma (NHL)

被引：0
|
作者：
Welt, A [1 ]
Fossa, A [1 ]
Blatter, J [1 ]
Buksmaui, S [1 ]
Seeber, S [1 ]
Nowrousian, MR [1 ]
机构：
[1] Univ Essen, Lilly Deutschland, W German Canc Ctr, Dept Med Oncol Canc Res, Bad Homburg, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
643
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [41] Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma
    Yang Xi-gui
    Jiang Chao
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3206 - 3211
  • [42] EFFICACY AND SAFETY OF DOSE-ADJUSTED EPOCH FOR RELAPSED AND REFRACTORY NON-HODGKIN LYMPHOMA (NHL)
    Suzuki, T.
    Harada, Y.
    Matsubara, E.
    Aoki, T.
    Oyama, T.
    Kasai, M.
    Uchida, T.
    Ogura, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 107 - 107
  • [43] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
  • [44] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [45] A Phase I/II Trial of Combination Gemcitabine and Bortezomib (VEL-CADE®) for Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma (NHL) and Aggressive B-Cell NHL
    Evens, Andrew M.
    Rosen, Steven T.
    Gordon, Leo I.
    Helenowski, Irene
    Kline, Justin
    Larsen, Annette
    Winter, Jane N.
    Smith, Sonali M.
    Van Besien, Koen M.
    BLOOD, 2011, 118 (21) : 715 - 716
  • [46] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Bernstein, J
    Myers, A
    Buchanan, LA
    Espina, BM
    Traynor, A
    Letzer, J
    Justice, GR
    McDonald, D
    Roberts, L
    Boswell, W
    Nathwani, B
    Levine, AM
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 457 - 462
  • [48] NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma
    Landells, Linda J.
    Prescott, Carl
    Hay, Nicola
    Sutcliffe, Frances
    Stevens, Andrew
    LANCET ONCOLOGY, 2014, 15 (04): : 381 - 382
  • [49] Pixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its use
    Keating G.M.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2017, 33 (4) : 160 - 166
  • [50] Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 339 - 339
12345